These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 28821097)

  • 1. Thiolated pectin-doxorubicin conjugates: Synthesis, characterization and anticancer activity studies.
    Cheewatanakornkool K; Niratisai S; Manchun S; Dass CR; Sriamornsak P
    Carbohydr Polym; 2017 Oct; 174():493-506. PubMed ID: 28821097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive microbeads containing thiolated pectin-doxorubicin conjugate inhibit tumor growth and metastasis: An in vitro and in vivo study.
    Cheewatanakornkool K; Niratisai S; Dass CR; Sriamornsak P
    Int J Pharm; 2018 Jul; 545(1-2):1-9. PubMed ID: 29702240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and
    Cheewatanakornkool K; Niratisai S; Manchun S; Dass CR; Sriamornsak P
    Asian J Pharm Sci; 2017 Nov; 12(6):509-520. PubMed ID: 32104364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ gellable oxidized citrus pectin for localized delivery of anticancer drugs and prevention of homotypic cancer cell aggregation.
    Takei T; Sato M; Ijima H; Kawakami K
    Biomacromolecules; 2010 Dec; 11(12):3525-30. PubMed ID: 21028797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
    Borker S; Pokharkar V
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):826-835. PubMed ID: 29749275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro characterization of entirely S-protected thiolated pectin for drug delivery.
    Hintzen F; Hauptstein S; Perera G; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1266-73. PubMed ID: 24095893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal.
    Ouyang J; Yang M; Gong T; Ou J; Tan Y; Zhang Z; Li S
    PLoS One; 2020; 15(6):e0235090. PubMed ID: 32569270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and encapsulation of doxorubicin on smart pectin hydrogels for oral delivery.
    Bosio VE; Machain V; López AG; De Berti IO; Marchetti SG; Mechetti M; Castro GR
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1365-76. PubMed ID: 22415787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and In Vitro Evaluation of Bispecific Complexes and Drug Conjugates of Anticancer Peptide, LyP-1 in Human Breast Cancer.
    Timur SS; Bhattarai P; Gürsoy RN; Vural İ; Khaw BA
    Pharm Res; 2017 Feb; 34(2):352-364. PubMed ID: 27896591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucoadhesive Properties of Thiolated Pectin-Based Pellets Prepared by Extrusion-Spheronization Technique.
    Martins AL; de Oliveira AC; do Nascimento CM; Silva LA; Gaeti MP; Lima EM; Taveira SF; Fernandes KF; Marreto RN
    J Pharm Sci; 2017 May; 106(5):1363-1370. PubMed ID: 28159639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of a multifunctional gold-doxorubicin nanoparticle system for pH triggered intracellular anticancer drug release.
    Khutale GV; Casey A
    Eur J Pharm Biopharm; 2017 Oct; 119():372-380. PubMed ID: 28736333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.
    Zhu S; Hong M; Tang G; Qian L; Lin J; Jiang Y; Pei Y
    Biomaterials; 2010 Feb; 31(6):1360-71. PubMed ID: 19883938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
    Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
    Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
    Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs.
    Chen W; Zou Y; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
    Biomacromolecules; 2014 Mar; 15(3):900-7. PubMed ID: 24460130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.